Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Growit (also marketed as Dr. Gil Growit) is a multi-ingredient dietary supplement formulated as a film-coated tablet for children and adolescents aged 6 to 18 years. Developed and manufactured by the Iranian company Razan Pharmed Iranian, the supplement is designed to support physical growth, height increase, bone density, immune function, and nervous system health. Its formulation contains L-arginine, folate (as methyltetrahydrofolate glucosamine), vitamin K2, selenium, vitamin B6, vitamin B12, vitamin B5, vitamin A, vitamin C, iodine, zinc, calcium, and vitamin D3. L-arginine in the supplement acts as a precursor for nitric oxide and stimulates growth hormone secretion, while calcium, vitamin D3, and vitamin K2 support bone mineralization and development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Growit.